I wonder how long these pharma-Trump deals will last, and how much $ is even saved by the American people while $$$ wasted on lawyers, when government shutdown is looming and new drugs that save patients might be put on hold because FDA closes for approving NDAs… Life’s easier

Important work - clear manufacturing controls seem rational and feasible, though they may impact other biotech workflows. Glad to see more red teaming; we need it in the rapidly evolving AI biology space.

The state of the world today Biotech economics needs change and AI hypes gotta chill out

I wish we could eliminate animal studies, but it will take years to validate alternative models, and funding this costly process remains uncertain—current economics seem just not viable. As it stands: - Animal studies are far cheaper than Phase 2/3 failures. - Most studies fail

Wow.

Great news showing biotech is picking back up, but curious how they ran the bidding / deal to get such a big upfront for a preclinical asset? Anyhoo huge congrats to the team!!

USA needs to invoke Defense Production Act, streamline environmental regulations, and fund $20-$50B to Elon and a couple others to fix our strategic minerals supply chain within 12 months. Likely doable, but not without more aggressive plan.

Pertinent Foreign Affairs article from Todd Young this morning, the US needs to work with allies and private sectors to lead in biotech, or risk falling behind foreignaffairs.com/united-states/…

k, sometimes u don’t realize things until someone points them out. proud of our crew this yr.

Really cool work by Dawn Chen on RNA splicing for cell-type specific expression!

We need more healthcare leaders engaging this way to fix the pharma PR problem, build trust, align incentives, and help therapies reach patients better

Everyone go see the Monkey King at the SF Opera NOW, what an incredible production

Great data dense presentation w/ strong case for innovation (63% of Pharma revenue from externally sourced assets, LOEs will continue to drive M&A, hypercrowding) w/ appropriate skepticism about AI and obesity hype “priced to perfection” China learnings, productivity lens,

Fascinating to see the Trump administration continuing to take stakes in private companies. This is one way to experiment with an overdue American sovereign wealth fund while addressing national security concerns. It's unclear how they plan to exit these stakes later, but I hope

Many have called it the Manhattan project of our time! But what will its metric of success be?